Key Statistics

WHY CBCC

Delivering Cutting Edge Outcomes

Team size of 200+ across USA and INDIA

Highly experienced team with about 50% staff having >10 years of clinical trial experience

100+ trials executed to date across 300+ sites

Database of 500+ sites across therapeutic areas

Have supported 40+ ANDA, 15+ MAA, and 18+ 505(b)(2) NDA submissions

Working relationships with clients from the US, EU, China, South Korea, and India

Participated in 25+ scientific advisory meetings with USFDA, EMA, CDSCO

Robust experience across 10+ therapeutic areas

Handled a wide range of studies from complex FIH studies to late phase trials with a sample size of up to 1500 patients

Experience of working on trials with lengthy patient follow-ups (up to 5 years)

Track record of 90% patient retention across therapeutic areas

Handled 10+ complex studies and 5+ rescue studies

Experience across 9+ EDC platforms

Global Library of 250+ standard CRFs

200+ deliverables like Interim analysis, dose-escalation meeting, DSMB, marketing authorization etc.